| Life Sciences Tools & Services Industry | Healthcare Sector | Mr. Martin Helbo Behrens CEO | XDUS Exchange | - ISIN |
| Denmark Country | 174 Employees | - Last Dividend | - Last Split | 18 Dec 2006 IPO Date |
Established in 1997 and headquartered in Allerød, Denmark, ChemoMetec A/S specializes in the innovation, manufacturing, and marketing of analytical instruments for cell counting and analysis. The company's global footprint spans across the United States, Canada, Europe, and other international markets. ChemoMetec’s solutions are pivotal in crucial research and development fields such as cell-based therapy, oncology, stem cell research, pharmaceutical development and manufacturing. In addition, the company extends its technological advancements to the production and quality control of animal semen and beer, showcasing the versatility and broad application spectrum of its products. With a focus on delivering accurate, dependable analytical tools, ChemoMetec continues to contribute significantly to advancements in healthcare, veterinary science, and quality control across various industries.
In addition to these state-of-the-art instruments, ChemoMetec A/S provides a comprehensive range of consumables including cassettes, reagents, and slides to support the operation of its devices. Accessories such as cables, power supplies, software, and labware further enhance the utility and application of ChemoMetec’s offerings. The company also offers detailed service and validation plans, ensuring that their products continue to operate at peak performance for their clients.